Today is a bittersweet day.
It’s bitter because today is the last day of our 1 to 30 Hypergrowth campaign. Three weeks ago, Wall Street icon Louis Navellier and I set out to change your financial future by launching a portfolio of seven hypergrowth technology stocks with 30X upside potential. A week later, I launched an eighth pick. A week after that, I launched our ninth pick. Today, though, we’re closing the book on this amazing opportunity, so your window to access nine different stocks with 30X upside potential is closing.
But it’s sweet because we’re going out with a bang. In celebration of your final opportunity to plug into the 1 to 30 Hypergrowth phenomenon, we’re unveiling a final 10th stock pick with 30X upside potential after the market closes today. Trust me when I say this could be our best pick yet.
Let me tell you a little bit about this amazing opportunity…
The Life-Saving Potential of Psychedelics
To start, folks, I’d like to tell you about an absolutely remarkable man by the name of Jonathan M. Lubecky.
He honorably served in both the Marine Corps and the Army from 1995 to 2009. While serving, Lubecky was deployed to active combat zones in Iraq. In the midst of the Iraq War, Lubecky’s Balad base was hit approximately 6,000 times with mortars, bombs, and rockets.
It was intense – so intense that when Lubecky returned to America, he struggled with post-traumatic stress disorder (PTSD), as so many of our noble veterans unfortunately do…
His PTSD was particularly bad. Lubecky fought off suicidal thoughts for a long time. But those thoughts wouldn’t go away, and so one day, Lubecky put a Beretta 9MM gun to his head and pulled the trigger.
But the gun malfunctioned, and Lubecky took that as a sign he was meant to live – to keep fighting his PTSD, and eventually, win. But, despite this sign, he was missing the tools to help him do that.
Until he started reading about MDMA on the internet, and its unique ability to be a “cure” for PTSD in some folks.
He was intrigued. And soon after, Lubecky found himself at the Multidisciplinary Association for Psychedelic Studies (or MAPS, for short) research center in Santa Cruz, California.
There, he met with professionals and was put on an MDMA-inspired therapy routine for his PTSD.
It worked wonders.
Lubecky found that the mind-altering characteristics of MDMA calmed his PTSD in ways that traditional medicine had not, and enabled him to feel embraced in ways he had not felt since before the Iraq War.
It saved Lubecky’s life.
The Return of Psychedelics in the Public Consciousness
As it turns out, Lubecky isn’t the only one whose life has been saved by MDMA, or LSD, or ketamine, or “magic mushrooms.”
All of those drugs belong in a class of drugs we call “psychedelics,” and traditionally, they’ve been frowned upon by society… but things weren’t always like that…
Let’s rewind 70 years.
Back in the 1950s, a group…